Cytori Therapeutics To Present at the 25 th Annual Roth Conference on March 18

SAN DIEGO--(BUSINESS WIRE)-- Cytori Therapeutics Inc. (NAS: CYTX) will present and provide a corporate update from the 25th Annual Roth Conference on Monday, March 18 at 4:30 PM PT.

The presentation will be webcast and may be accessed under "Webcasts" under Cytori's Investor Relations section of the website. The webcast can be viewed live and will be available for replay after the presentation on the Company's website.

About Cytori

Cytori Therapeutics, Inc. is developing cell therapies based on autologous adipose-derived regenerative cells (ADRCs) to treat cardiovascular disease and repair soft tissue defects. Our scientific data suggest ADRCs improve blood flow, moderate the inflammatory response and keep tissue at risk of dying alive. As a result, we believe these cells can be applied across multiple "ischemic" conditions. These therapies are made available to the physician and patient at the point-of-care by Cytori's proprietary technologies and products, including the Celution® system product family.

Cytori Therapeutics Inc.
Megan McCormick, +1-858-875-5279

KEYWORDS:   United States  North America  California


The article Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18 originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Increase your money and finance knowledge from home

Introduction to Economic Indicators

Measure the performance of the economy.

View Course »

Investing Like Warren Buffett

Learn from one of the world's best investors.

View Course »

Add a Comment

*0 / 3000 Character Maximum